| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/FON.15.252 |
| P698 | PubMed publication ID | 26551415 |
| P50 | author | Vijaya Raj Bhatt | Q84159877 |
| P2093 | author name string | Janak Adhikari | |
| Priyadarshani Sharma | |||
| P2860 | cites work | American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer | Q24607403 |
| Hematopoietic stem cell transplantation: a global perspective | Q24624697 | ||
| Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer | Q28262641 | ||
| Frequent genomic alterations in epithelium measured by microsatellite instability following allogeneic hematopoietic cell transplantation in humans | Q33230040 | ||
| Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation | Q33710708 | ||
| Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis | Q33732489 | ||
| Increased risk of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation--implications for screening and HPV vaccination | Q34158682 | ||
| Second solid cancers after allogeneic hematopoietic cell transplantation using reduced-intensity conditioning | Q34325244 | ||
| Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study | Q34554733 | ||
| Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning | Q34568905 | ||
| How we treat chronic graft-versus-host disease | Q35004923 | ||
| Long-term survival and late deaths after allogeneic hematopoietic cell transplantation | Q35023409 | ||
| Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up | Q35184667 | ||
| Subsequent malignant neoplasms after hematopoietic cell transplantation | Q35678455 | ||
| Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation | Q35757247 | ||
| Second malignant neoplasms following hematopoietic stem cell transplantation | Q35787499 | ||
| Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study | Q36141716 | ||
| Mechanisms of therapy-related carcinogenesis | Q36315585 | ||
| Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party | Q36384739 | ||
| DNA damage and repair in epithelium after allogeneic hematopoietic stem cell transplantation | Q36538311 | ||
| Pharmacogenetics of alkylator-associated acute myeloid leukemia. | Q36555916 | ||
| Oral graft-versus-host disease. | Q36932886 | ||
| Thyroid function following hematopoietic cell transplantation in children: 30 years' experience | Q37041913 | ||
| Solid cancers after allogeneic hematopoietic cell transplantation | Q37082013 | ||
| Accelerated telomere shortening precedes development of therapy-related myelodysplasia or acute myelogenous leukemia after autologous transplantation for lymphoma | Q37103073 | ||
| Can routine posttransplant HPV vaccination prevent commonly occurring epithelial cancers after allogeneic stem cell transplantation? | Q37285453 | ||
| Oral carcinoma after hematopoietic stem cell transplantation--a new classification based on a literature review over 30 years | Q37298879 | ||
| Secondary cancers following allogeneic haematopoietic cell transplantation in adults | Q37880254 | ||
| Uses of non-invasive imaging in the diagnosis of skin cancer: an overview of the currently available modalities | Q38164826 | ||
| Breast MRI as an adjunct to mammography for breast cancer screening in high-risk patients: retrospective review | Q38385382 | ||
| Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation | Q42490487 | ||
| Skin cancer after nonmyeloablative hematopoietic cell transplantation | Q42496514 | ||
| Second solid cancers after allogeneic hematopoietic stem cell transplantation | Q42504740 | ||
| Incidence and susceptibility to therapy-related myeloid neoplasms. | Q43212751 | ||
| Incidence of breast cancer among female survivors of Hodgkin lymphoma: a US-population-based trend analysis from 1973 to 2011. | Q43690048 | ||
| Long-term survival after blood and marrow transplantation: comparison with an age- and gender-matched normative population | Q44235772 | ||
| Increased risk of colon cancer after external radiation therapy for prostate cancer | Q44526216 | ||
| Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma | Q45854491 | ||
| Solid cancers after bone marrow transplantation | Q47582581 | ||
| New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors | Q48006715 | ||
| Solid cancers after bone marrow transplantation | Q48760643 | ||
| Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. | Q50772733 | ||
| Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants. | Q50910580 | ||
| A clinical study of cervical dysplasia in long-term survivors of allogeneic stem cell transplantation. | Q51407242 | ||
| Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. | Q51750812 | ||
| Identification of candidate alkylator-induced cancer susceptibility genes by whole genome scanning in mice. | Q53346091 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3175-3185 | |
| P577 | publication date | 2015-11-09 | |
| P1433 | published in | Future Oncology | Q2781597 |
| P1476 | title | Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies | |
| P478 | volume | 11 |
| Q38673277 | "From Snail Mode to Rocket Ship Mode": Adolescents and Young Adults' Experiences of Returning to Work and School After Hematopoietic Cell Transplantation |
| Q38727798 | Addressing inherited predisposition for breast cancer in transplant recipients |
| Q41923053 | Central nervous system complications after allogeneic hematopoietic stem cell transplantation |
| Q48183641 | Hematopoietic stem cell transplantation in children with Griscelli syndrome: A single-center experience. |
| Q91688305 | Risk of Head and Neck Cancer in Patients With Prior Hematologic Malignant Tumors |
| Q90291771 | Second primary cancers in long-term survivors of glioblastoma |
| Q92473866 | Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia |
Search more.